Register entry
Changzhou Pharmaceutical Factory
- Registered sites
- 1
- Drug products
- 11
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Changzhou Pharmaceutical Factory | ChangzhouChina | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3002806661 |
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Captopril | POWDER | BULK INGREDIENT |
| - | Doxycycline | POWDER | BULK INGREDIENT |
| - | Doxycycline Hyclate | POWDER | BULK INGREDIENT |
| - | Hydrochlorothiazide | POWDER | BULK INGREDIENT |
| - | Lenalidomide | POWDER | BULK INGREDIENT |
| - | Rosuvastatin Calcium | POWDER | BULK INGREDIENT |
| Ticagrelor | Ticagrelor | TABLET | ANDA |
| Ticagrelor | Ticagrelor | TABLET | ANDA |
| rivaroxaban | rivaroxaban | TABLET, FILM COATED | ANDA |
| rivaroxaban | rivaroxaban | TABLET, FILM COATED | ANDA |
| rivaroxaban | rivaroxaban | TABLET, FILM COATED | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.